Biense Visser's Email Addresses & Phone Numbers

📖 Summary

I have a sincere interest in businesses active in lifesciences and with a clear ambition to grow in the international market. My profesional experience in life sciences started with human blood products, moved then to generic pharmaceuticals via vegetable seeds to currently trauma products. Growth in the international arena started with the FDA license to export human serum albumin in the early '80's at Sanquin, continued with the FDA approval of the Pharmachemie sterile dosage facility in 1994 and the supply of oncology products to Astra USA, COPD product registrations in EU and a license and supply agreement with Novartis. Pharmachemie grew from EUR 5M in 1986 to EUR 125 M in in 1998 at the moment of acquisition by TEVA . The strategic focus on oncology, pain and COPD together with the ambitious team were the key succes factors. DeRuiterSeeds grew from EUR 55 M in 2002 to EUR 110M in 2007 at the moment of acquisition by Monsanto.The focus on 4 crops, on IP protection, excellent supply chain management and the empowerment of a wide range of diverse managers from the USA ,Mexico ,Guatemala ,Spain to Japan and Israel were of great importance. At TEVA Pharmaceuticals I had the privilege as President EU to be part of the MB under the leadership of Eli Hurvitz and Israel Makov and learning the importance of Strategy, Profitable Growth, Disciplined Implmentation and International Diversity for success in growing business and creating value. Having succesfully applied these principles in various life-science businesses leads me to believe that these principles have universal value. Turning aap Implantate AG from a diversified loss making, highly indebted healthcare company into an profitable, international Trauma company with an innovative portfolio of IP protected products has provided another example. The entreprise value has increased 10x in the period 1/09-05/14 and in 2013 positive Ec.Profit has been realized.CEO @ A challenge and an honor to joint this leading horticulture company with colleagues in AFrica, Asia, Europe, Laten Amirica and the USA, all sharing the ambition to create customer Solutions and capitalize on growth opportunities in the value chains. From June 2014 to Present (1 year 7 months) Chairman of the Board of Directors @ From June 2014 to Present (1 year 7 months) Berlin Area, GermanyMember Supervisory Board @ I am of the 2 non cooperative members, my role is basically to contribute especially an " outside -in " perspective From November 2011 to Present (4 years 2 months) Breda Area, NetherlandsChairman of the Supervisory Board @ From December 2006 to Present (9 years 1 month) CEO @ aap AG is a medtech company focussing on Trauma ((LOQTEQ,cannulated screws), Biomaterials like Cement and Services like like allograft sterilization with SCCO2. Products are world class and approved in USA,EU,China;Brasil; South Africa,India and Russia. Development projects on hybrid products of trauma/biomaterials like silver coating, antibiotic loading of trauma/bone products. B2B customers like Aeskulap,Biomet, DePuy,,Hereaus, Mathys,Sanquin,Stryker, Zimmer From January 2009 to May 2014 (5 years 5 months) Director @ From December 2010 to December 2012 (2 years 1 month) member Supervisory Board @ From April 2004 to June 2012 (8 years 3 months) CEO @ From 2002 to 2008 (6 years) President EU @ From 1999 to 2002 (3 years) president @ From July 1986 to June 1998 (12 years) Department of Blood Products @ From September 1981 to June 1986 (4 years 10 months) MBA @ Nyenrode Business Universiteit From 1988 to 1990 Master, Pharmacy @ From 1969 to 1978 Biense Visser is skilled in: Veränderungsmanagement, Strategisches Management, Unternehmensstrategie, Pharmaindustrie, Business Strategy, Biotechnologie, Biowissenschaften